Bayer sues Pfizer, Moderna, J&J and BioNTech over alleged Covid vaccine patent breach

Bayer sues Pfizer, Moderna, J&J and BioNTech over alleged Covid vaccine patent breach
Bayer sues Pfizer, Moderna, J&J and BioNTech over alleged Covid vaccine patent breach

Hello and welcome to the details of Bayer sues Pfizer, Moderna, J&J and BioNTech over alleged Covid vaccine patent breach and now with the details

Nevin Al Sukari - Sana'a - Numerous lawsuits have since been launched over the use of the technology. — Reuters file pic

Advertisements

(New users only) Unlock 4%* + 10%* p.a. promo rate for 3 months and enjoy FREE RM10 & when you sign up using code VERSAMM10 with min. cash of RM100 today! T&Cs apply.

FRANKURT, Jan 8 — German agrichemical giant Bayer confirmed to AFP today that it was suing American pharmaceutical firms Pfizer, Moderna and Johnson & Johnson as well as Germany’s BioNTech, alleging they broke a patent to make Covid jabs.

The defendants allegedly used a patented mRNA process developed in the 1980s by US biotech firm Monsanto—now a Bayer subsidiary—as part of efforts to make crops more resistant to pests, according to suits filed in Delaware and New Jersey federal courts on Tuesday.

“This lawsuit alleges the defendants infringed on patented innovations owned by Bayer which increase mRNA stability and which Bayer initially used for agricultural purposes,” a Bayer spokesman said, alleging that this had allowed them to solve “one of the biggest challenges they faced during vaccine development”.

Biotech firm BioNTech collaborated with Pfizer to make the blockbuster Comirnaty coronavirus vaccine, the first to receive approval in the West, basing it on novel use of mRNA technology.

Moderna’s vaccine is also an mRNA product, while Johnson & Johnson’s delivers a genetically modified cold virus that triggers an immune response protective against Covid.

Pfizer, BioNTech and Johnson & Johnson did not immediately respond to requests for comment from AFP. Moderna said it was aware of the claims and would defend itself against them.

Unlike traditional vaccines which contain some form of target virus or its components, mRNA vaccines contain genetic materials that instruct human cells to make proteins typical of the targeted virus—allowing production to be scaled up more quickly since the virus need not be grown in the lab.

Numerous lawsuits have since been launched over the use of the technology.

In August, Pfizer and BioNTech reached a settlement worth $740 million plus royalties with Britain’s GSK and Germany’s CureVac over an mRNA dispute.

“Over the past several years, many companies and research institutions alleging that their technologies were used in the development of the vaccine have sued,” Bayer and Monsanto said in their suits against Pfizer and BioNTech as well as Moderna.

Bayer did not specify the amount it is seeking in damages but said in all suits that it wanted “basic compensation afforded to a patent holder under the patent statute”. — AFP

 

 

These were the details of the news Bayer sues Pfizer, Moderna, J&J and BioNTech over alleged Covid vaccine patent breach for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV Trump says US will dictate Venezuela’s interim leaders and control oil sales indefinitely
NEXT Global heatwave: 120 monthly temperature records broken across 70 countries in 2025

Author Information

I have been an independent financial adviser for over 11 years in the city and in recent years turned my experience in finance and passion for journalism into a full time role. I perform analysis of Companies and publicize valuable information for shareholder community. Address: 2077 Sharon Lane Mishawaka, IN 46544, USA Phone: (+1) 574-255-1083 Email: [email protected]